奥翔药业收盘下跌1.82%，滚动市盈率33.48倍，总市值71.49亿元

金融界2025-06-19

6月19日，奥翔药业今日收盘8.61元，下跌1.82%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到33.48倍，总市值71.49亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均52.37倍，行业中值30.11倍，奥翔药业排名第95位。股东方面，截至2025年3月31日，奥翔药业股东户数30806户，较上次减少11571户，户均持股市值35.28万元，户均持股数量2.76...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2544169046?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-19 19:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2544169046","market":"sh","top_or_hot":-1,"title":"奥翔药业收盘下跌1.82%，滚动市盈率33.48倍，总市值71.49亿元","media":"金融界","content":"<div>\n<p>6月19日，奥翔药业今日收盘8.61元，下跌1.82%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到33.48倍，总市值71.49亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均52.37倍，行业中值30.11倍，奥翔药业排名第95位。股东方面，截至2025年3月31日，奥翔药业股东户数30806户，较上次减少11571户，户均持股市值35.28万元，户均持股数量2.76...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/06/19195651177598.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>奥翔药业收盘下跌1.82%，滚动市盈率33.48倍，总市值71.49亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n奥翔药业收盘下跌1.82%，滚动市盈率33.48倍，总市值71.49亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-19 19:56 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.jrj.com.cn/2025/06/19195651177598.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月19日，奥翔药业今日收盘8.61元，下跌1.82%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到33.48倍，总市值71.49亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均52.37倍，行业中值30.11倍，奥翔药业排名第95位。股东方面，截至2025年3月31日，奥翔药业股东户数30806户，较上次减少11571户，户均持股市值35.28万元，户均持股数量2.76...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/06/19195651177598.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603229","symbol_name":"奥翔药业","start_time":0,"source_url":"https://finance.jrj.com.cn/2025/06/19195651177598.shtml","article_id":"2544169046","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2544169046","pubTimestamp":1750334184,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"6月19日，奥翔药业今日收盘8.61元，下跌1.82%，滚动市盈率PE达到33.48倍，总市值71.49亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均52.37倍，行业中值30.11倍，奥翔药业排名第95位。股东方面，截至2025年3月31日，奥翔药业股东户数30806户，较上次减少11571户，户均持股市值35.28万元，户均持股数量2.76万股。最新一期业绩显示，2025年一季报，公司实现营业收入3.07亿元，同比1.90%；净利润1.19亿元，同比5.97%，销售毛利率61.01%。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603229":"奥翔药业","BK0239":"医药制造"},"translate_title":"Aoxiang Pharmaceutical closed down 1.82%, with a rolling P/E of 33.48 times and a total market value of 7.149 billion yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603229":1},"content_text":"6月19日，奥翔药业今日收盘8.61元，下跌1.82%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到33.48倍，总市值71.49亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均52.37倍，行业中值30.11倍，奥翔药业排名第95位。股东方面，截至2025年3月31日，奥翔药业股东户数30806户，较上次减少11571户，户均持股市值35.28万元，户均持股数量2.76万股。浙江奥翔药业股份有限公司的主营业务是从事制剂、特色原料药及医药中间体的研发、生产与销售，以及为客户提供定制生产和研发业务。公司的主要产品是肝病类、抗菌类、心脑血管类、前列腺素类、高端氟产品类、痛风类、抗肿瘤类、神经系统类、其他类。目前，公司的成熟产品已有双环醇、恩替卡韦、西他沙星、泊沙康唑、非布司他、奈必洛尔、米格列醇等。经过多年化学合成的生产经验积累和技术工艺研发创新，公司形成了以合成装备完整先进、合成工艺成熟丰富、产业化能力强以及质量控制规范等为特征的化学原料药生产制造能力优势。最新一期业绩显示，2025年一季报，公司实现营业收入3.07亿元，同比1.90%；净利润1.19亿元，同比5.97%，销售毛利率61.01%。序号股票简称PE(TTM)PE(静)市净率总市值(元)13奥翔药业33.4834.573.0171.49亿行业平均52.3750.675.57129.56亿行业中值30.1130.412.3957.25亿1浙江医药9.4411.871.25137.80亿2新和成9.6611.322.17664.17亿3吉林敖东10.0912.520.66194.21亿4华润双鹤11.7211.671.74190.00亿5国药现代12.6112.961.04140.42亿6辰欣药业12.7612.281.0262.48亿7华特达因13.2313.582.2670.02亿8诚意药业13.4714.352.2228.80亿9哈药股份13.7514.541.6491.42亿10国邦医药13.8114.101.33110.20亿11健康元14.5014.461.37200.51亿12九典制药15.0715.072.9777.23亿","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2544169046","isCrawlerRequest":true}